Investigation on effects of Hibiscus sabdariffa L. on hemoglobin level of mice with phenylhydrazine-induced anemia

Authors

  • Isaac Pangson Department of Biological Sciences and Biomedical Health Sciences, University of Malawi, Zomba, Malawi
  • Yankho Kaimila Department of Biological Sciences and Biomedical Health Sciences, University of Malawi, Zomba, Malawi https://orcid.org/0000-0002-1650-9050
Article ID: 270
19 Views

DOI:

https://doi.org/10.18686/fnc270

Keywords:

Hibiscus sabdariffa L.; anemia; hemoglobin; phenylhydrazine-induced anemia; iron content

Abstract

With Sub-Saharan Africa having the highest prevalence of anemia globally and inequitable access to health care, traditional medicines are used by some of the population for treatment. Hibiscus sabdariffa L. (HS) is known to have medicinal applications, including its use in the treatment of anemia. The purpose of this study was to investigate the effect of HS on the hemoglobin level in anemic mice. A total of 15 mice were divided into three groups: Group A was the control group, while Groups B and C were the experimental groups, in which anemia was induced using phenylhydrazine. Only group C received oral administration of HS at 400 mg/kg. Blood samples were collected from the tail vein and analyzed using a HemoCue hemoglobin meter. The HS iron content was assessed using an atomic absorption spectrometer. The mean iron content for HS was 6.3 ± 0.6 mg/L. No significant difference (p = 0.359) was observed in the mean hemoglobin levels between Groups A and B, which were 14.88 g/dl and 13.78 g/dl respectively. Higher hemoglobin levels were observed when Group C (17.46 g/dl) was compared with Group A (p = 0.005) and Group B (p = 0.001). These findings suggest the efficacy of HS in improving the hemoglobin level in anemic mice. Further investigations on doses and the mechanism are needed before recommendations for human consumption.

References

1. Kraemer K. In: Nutritional anemia. Sight and Life Press; 2007.

2. Adamson P, MI/UNICEF. Vitamins & mineral deficiency: A global report. Available online: https://peteradamsonwriting.com/pla/vitamin-and-mineral-deficiency-a-global-report/ (accessed 22 June 2024).

3. Gardner WM, Razo C, McHugh TA, et al. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021. The Lancet Haematology. 2023; 10(9): e713–e734. doi: 10.1016/S2352-3026(23)00160-6

4. Adamu AL, Crampin A, Kayuni N, et al. Prevalence and risk factors for anemia severity and type in Malawian men and women: urban and rural differences. Population Health Metrics. 2017; 15(1): 12. doi: 10.1186/s12963-017-0128-2

5. Osungbade KO, Oladunjoye AO. Anaemia in Developing Countries: Burden and Prospects of Prevention and Control. In: Anemia, Silverberg D (editor). IntechOpen; 2012.

6. MacDonald C, Mildon A, Neequaye M, et al. Anemia—can its widespread prevalence among women in developing countries be impacted? Available online: https://www.wvi.org/sites/default/files/Anaemia-Ghana-Malawi-Chapter.pdf (accessed on 9 June 2024).

7. Yaye KGD, Djibril S, Mansor N. Direct genetic transformation of Hibiscus sabdariffa L. African Journal of Biotechnology. 2004; 3(4): 226–228. doi: 10.5897/ajb2004.000-2041

8. Mahadevan N, Shivali, Pradeep K. Hibiscus sabdariffa Linn.—An overview. Available online: http://nopr.niscpr.res.in/handle/123456789/3769 (accessed 14 June 2024).

9. Ahmed R, Hassan AA, Hadi HME, Khalifa MYE. The effect of aqueous extract of Hibiscus sabdariffa seeds on hematological parameters of anemic rats. International Journal of Phytomedicine. 2013; 5(3): 278–281.

10. Liu H, Liang ZM, Li R, Yu YG. Advances in the mechanisms of Hibiscus sabdariffa L. on hypertension. E3S Web of Conferences. 2020; 145: 01039. doi: 10.1051/e3sconf/202014501039

11. Mohamed BB, Sulaiman AA, Dahab AA. Roselle (Hibiscus sabdariffa L.) in Sudan, Cultivation and Their Uses. Bulletin of Environment, Pharmacology and Life Sciences. 2012; 1(6): 48—54.

12. Odigie IP, Ettarh RR, Adigun SA. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats. Journal of Ethnopharmacology. 2003; 86(2–3): 181–185. doi: 10.1016/s0378-8741(03)00078-3

13. Diallo A, Gbeassor M, Vovor A, et al. Effect of Tectona grandis on phenylhydrazine-induced anaemia in rats. Fitoterapia. 2008; 79(5): 332–336. doi: 10.1016/j.fitote.2008.02.005

14. Clarke L, Dodds AJ. Iron deficiency anaemia: Causes, symptoms and treatment. Medicine Today. 2014; 15(11): 36–42.

15. Gassama-Dia YK, Sané D, Ndoye M. Direct genetic transformation of Hibiscus sabdariffa L. African Journal of Biotechnology. 2004; 3(4): 226–228. doi: 10.5897/ajb2004.000-2041

16. Oyewole AO, Diosady LL. Evaluating the potential of Hibiscus sabdariffa beverage to address the prevalence of iron deficiency in sub-Saharan Africa. LWT. 2023; 188: 115433. doi: 10.1016/j.lwt.2023.115433

17. Platel K, Srinivasan K. Bioavailability of Micronutrients from Plant Foods: An Update. Critical Reviews in Food Science and Nutrition. 2016; 56(10): 1608–1619. doi: 10.1080/10408398.2013.781011

Downloads

Published

2024-06-23

How to Cite

Pangson, I., & Kaimila, Y. (2024). Investigation on effects of Hibiscus sabdariffa L. on hemoglobin level of mice with phenylhydrazine-induced anemia. Food Nutrition Chemistry, 2(2), 270. https://doi.org/10.18686/fnc270

Issue

Section

Article